U.S. REITS Stock News

Multiple securities class action lawsuits have been filed against Boston Scientific (NYSE:BSX) alleging misrepresentation of growth prospects in its U.S. Electrophysiology segment. The suits follow mixed guidance from the company and rising competitive pressure in the electrophysiology market. At the same time, Boston Scientific reported positive data from the CHAMPION-AF and HI-PEITHO trials and secured FDA clearance for the Asurys Fluid Management System. These legal actions and clinical...

Glaukos recently reported strong business momentum, with robust top-line sales growth and improving profit trends that align with growth-focused technical criteria such as the Minervini Trend Template. This combination of accelerating revenue and a strengthening earnings trajectory suggests that the company’s operational performance is increasingly underpinning investor confidence in its outlook. Now, we’ll examine how this improving sales and profit profile affects Glaukos’ existing...

Teradyne snapshot: what recent returns and financials tell investors Teradyne (TER) has attracted attention after a strong past 3 months, with a total return above 40% and a 1 year total return above 300%. This has prompted closer scrutiny of its fundamentals. The company reports annual revenue of US$3.19b and net income of US$554.05m, with both revenue and net income growth reported on an annual basis. These figures give investors a starting point for assessing current pricing. See our...

How Public Storage (PSA) Has Been Performing Recently Public Storage (PSA) has drawn fresh investor attention after a period of mixed share performance, with a recent daily gain of about 1.5% contrasting with a decline over the past month and a positive move in the past 3 months. Over the past year, the stock shows a small negative total return, while the past 3 years and past 5 years reflect positive total returns. That backdrop sets the stage for looking more closely at how the business is...

AM Best recently upgraded Arch Wilsure Insurance Company’s Financial Strength Rating to A+ (Superior) and Long-Term Issuer Credit Rating to “aa” (Superior), assigning stable outlooks that signal increased confidence in its balance sheet and integration within Arch Capital Group. At the same time, Arch Capital Group’s pattern of earnings surprises and analyst optimism about its upcoming results highlight how credit strength and earnings momentum are working together to reshape expectations...

In late March 2026, Broadridge Financial Solutions reported Q2 2026 results that exceeded analyst expectations, raised its recurring revenue and adjusted EPS growth outlook, and highlighted ongoing investment in digital assets and tokenization capabilities. Investor attention was further drawn by CEO Timothy C. Gokey’s insider share purchase and the company’s latest Fund Brand 50 report, underscoring Broadridge’s influence across asset management branding and financial technology...

Hut 8 (NasdaqGS:HUT) has registered to open a new office in Dubai, its first physical presence in the Middle East. The move comes during a period of heightened geopolitical tension involving the U.S., Israel, and Iran. Recent missile and drone attacks in Dubai frame the decision as a higher risk geographic expansion. The company aims to sharpen international capital deployment and explore new markets for computing infrastructure and digital assets. Hut 8, listed on NasdaqGS:HUT, is known...

Braze (BRZE) has been back in focus after Q4 results and guidance triggered a strong reaction from the market, with investors weighing faster organic revenue growth, heavier enterprise bookings and growing adoption of the company’s AI tools. See our latest analysis for Braze. At a share price of US$23.68, Braze’s 30 day share price return of 20.88% contrasts with a 90 day share price return of a 27.25% decline and a 1 year total shareholder return of a 27.67% loss. This points to improving...

Why Uniti Group Stock Has Caught Investor Attention Uniti Group (UNIT) has drawn fresh interest after a recent stretch of strong share price moves, including solid gains over the past week, month, and past 3 months, prompting closer scrutiny of its fundamentals. See our latest analysis for Uniti Group. The recent 31.6% 7 day share price return and 51.2% year to date share price return, alongside a 26.1% 1 year total shareholder return and 131.3% 3 year total shareholder return, point to...

In recent days, Jefferies upgraded Expedia Group to a Buy rating and highlighted the company’s strong B2B performance, AI investments, and institutional interest, while Expedia also secured a new US$2.50 billion unsecured revolving credit facility maturing in 2031 to enhance its financial flexibility. Asset managers such as Artisan Partners underscored Expedia’s expanding AI-powered travel platforms, disciplined capital allocation, and solid free cash flow profile, reinforcing confidence in...

Recent Q4 earnings and fresh moves in oil prices after U.S. Iran tensions eased have pushed Coterra Energy (CTRA) into focus, giving you a live case study in how geopolitics and fundamentals interact. See our latest analysis for Coterra Energy. Coterra’s share price has been volatile around these oil headlines and Q4 results, with a 1 month share price return of 11.84% and a year to date gain of 29.92%. The 5 year total shareholder return of 151.27% points to momentum that has built over a...

In March 2026, Qualys, Inc. launched Agent Val within its Enterprise TruRisk Management platform, introducing AI-led exploit validation and autonomous risk remediation for security teams’ Risk Operations Centers. By shifting vulnerability management from assumption-based prioritization to evidence-backed validation, Agent Val aims to cut remediation noise, sharpen focus on truly exploitable risks, and give organizations clearer proof of cyber risk reduction. Next, we’ll examine how Agent...

Walt Disney (NYSE:DIS) has reportedly terminated a planned $1b AI partnership with OpenAI that would have licensed over 200 characters for AI generated video content. The cancellation, described as abrupt and unexpected for Disney, highlights financial and operational risks around large scale AI and media collaborations. At the same time, multiple Disney directors have recently purchased company shares, signaling fresh internal views on the company’s prospects. Disney shares most recently...

Starbucks (NasdaqGS:SBUX) has completed a major China joint venture with Boyu Capital, altering the ownership structure of its China retail operations. The company is rolling out new U.S. employee programs, including performance based bonuses, weekly pay, and expanded digital tipping for baristas. These changes affect one of Starbucks' most important international markets and reshape its approach to labor in the U.S. Starbucks shares last closed at $90.37, with mixed recent returns that...

CRISPR Therapeutics (CRSP) has caught investor attention after becoming the first gene editing peer to generate commercial revenue from its approved therapy Casgevy, supported by Vertex Pharmaceuticals and a sizable cash cushion for upcoming trials. See our latest analysis for CRISPR Therapeutics. CRISPR Therapeutics’ recent news on Casgevy and upcoming trial milestones comes after a sharp 1 year total shareholder return of 51.59%, even as the 30 day share price return of 14.73% and 90 day...

Exxon Mobil (XOM) is back on many investors’ screens after a recent move in its share price, with the stock posting a return over the past month and a stronger gain over the past three months. See our latest analysis for Exxon Mobil. Even with a 2.9% 7 day share price pullback, Exxon Mobil’s recent 30 day share price return of 5.8% and year to date share price return of 31.0% suggest momentum has been strong. The 1 year total shareholder return of 47.8% and 5 year total shareholder return of...

Nike (NKE) just reported fiscal Q3 results that topped earnings expectations, but the real shock for investors came from management’s outlook, which calls for a 2% to 4% revenue decline next quarter. See our latest analysis for NIKE. The guidance reset has fed straight into the share price, with Nike now trading at US$44.19 after a 30.17% year to date share price decline and a 64.34% five year total shareholder return loss, signaling fading momentum as investors reassess execution risk and...

In March 2026, the Public Health Advocacy Institute filed a landmark product liability lawsuit in Pennsylvania against DraftKings, FanDuel, Genius Sports, and the NFL, alleging their online platforms use AI‑driven microbetting features and intensive promotions that foster gambling addiction and violate consumer protection laws. This case sharpens focus on how online sportsbooks monetize live in-game microbets and VIP-style inducements, raising questions about product design, data use, and...

In March 2026, Amprius Technologies, Inc. announced it had secured a US$21,000,000 purchase order from a new premier electric mobility customer in China for its high-energy-density SiCore cylindrical cells, to be used in light electric vehicles such as scooters, three-wheelers, and motorcycles. An interesting aspect of this deal is that it extends Amprius’ silicon-anode battery technology beyond drones and aviation into the growing light electric vehicle market, potentially broadening its...

What Hubbell's Recent Share Move Signals for Investors Hubbell (HUBB) has attracted fresh attention after a recent pullback of about 1% in the latest session, even as its shares show gains over the past week, month, and past three months. See our latest analysis for Hubbell. Following the latest 1.23% one day share price decline to US$494.25, Hubbell’s 6.74% year to date share price return and 55.71% one year total shareholder return indicate momentum that has been building rather than...

Conagra Brands (CAG) just reported third quarter results that topped revenue expectations but narrowly missed earnings per share forecasts, while also tightening 2026 guidance and highlighting ongoing pressure from input costs and softer margins. See our latest analysis for Conagra Brands. The latest results land against a weak share price backdrop, with a 30 day share price return of 17.09% and a 1 year total shareholder return loss of 36.88%, which points to fading longer term momentum...

In March 2026, Eisai and Nuvation Bio reported that the European Medicines Agency validated their Marketing Authorisation Application for taletrectinib to treat advanced ROS1-positive non-small cell lung cancer, following existing approvals in the US, China and Japan. This regulatory milestone could broaden taletrectinib’s geographic reach under Eisai’s licensing deal, potentially deepening Nuvation Bio’s role in targeted lung cancer treatment across Europe and other Eisai territories. We’ll...

If you are wondering whether Ventas at around US$83.27 offers fair value or a potential mismatch between price and fundamentals, this article walks through the key signals to watch. The stock has returned 0.7% over the last 7 days, 7.7% year to date and 22.9% over the past year, alongside a 3 year return of 115.3% and a 5 year return of 79.6%, which raises questions about how much optimism is already in the price. Recent coverage has focused on Ventas as a major health care REIT, with...

Why Ford Motor (F) is on investors’ radar today Ford Motor (F) continues to draw attention as investors weigh its recent share performance against the company’s scale, with a market value of about US$46.8b and annual revenue of roughly US$187.3b. See our latest analysis for Ford Motor. Recent share price moves have been softer, with a 30 day share price return of 8.66% and a year to date share price return of a 13.04% decline, while the 1 year total shareholder return of 27.84% points to...